Generating safe antigens to induce immunity is one of several key steps in vaccine production. Purification is another, and it is typically a complex process. EU-funded researchers have designed a way to simplify the process, boost yields, limit waste and reduce costs, in a bid to help make more doses available more affordably.
EU-funded researchers have developed an ultrasensitive test to rapidly, accurately and cost-effectively diagnose disease, underpinned by innovative biosensing technology that could help combat the COVID-19 pandemic, HIV and cancer.
EU-funded researchers have employed quantum physics to develop an optical microscope that opens up the potential to view the tiniest of objects - including many viruses - directly for the first time.
A revolutionary approach to neuro-rehabilitation developed by EU-funded researchers could help intensive care patients to recover, including survivors of the COVID-19 pandemic.
An EU-funded project has linked scientists with experts in industry to forge partnerships aimed at creating new products to improve the lives of people with dementia. The research is creating tools to help remind people with dementia to undertake the tasks critical to their daily lives.
EU-funded researchers have developed innovative genetic reprogramming techniques to replace and repair brain cells, opening up novel therapeutic pathways to combat debilitating disorders such as Parkinson's and Huntington's disease.
Treatment guidance for prostate cancer patients is not optimal because current clinical tests do not clearly differentiate between slow-growing and aggressive forms. An EU-funded project is addressing this by studying the underlying molecular mechanisms of the disease to enable personalised and effective treatment.
EU-funded researchers hope a greater understanding of interactions between pertussis bacteria and the immune system, together with a toolkit for testing new vaccines, will help prevent whooping cough disease and deaths in babies worldwide.
A medicine developed by EU-funded researchers has been approved to treat children with the degenerative and fatal genetic disease Duchenne muscular dystrophy. A major clinical trial is expected to announce positive results soon.
Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.
